Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Zoulim

Showing results (21-30 of 499) with videos related to

Pageof 50
Sort By:
Journal of Hepatology|May 24, 2003
Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?Fabien Zoulim
Antiviral Research|September 25, 2012
Are novel combination therapies needed for chronic hepatitis B?Fabien Zoulim
Gastroenterologie Clinique Et Biologique|April 9, 2002
[Toward the expected development of therapeutic combinations in hepatitis B?]Fabien Zoulim
Expert Opinion on Emerging Drugs|July 3, 2007
Emerging drugs for hepatitis BFabien Zoulim
Journal of Hepatology|February 16, 2005
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNAFabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Hepatitis B virus resistance to antiviral drugs: where are we going?Fabien Zoulim
Presse Medicale (Paris, France : 1983)|November 29, 2007
[Current data on the treatment of chronic hepatitis B]Fabien Zoulim
Journal of Hepatology|December 9, 2017
Inhibition of hepatitis B virus gene expression: A step towards functional cureFabien Zoulim
Seminars in Liver Disease|May 5, 2006
In vitro models for studying hepatitis B virus drug resistanceFabien Zoulim
Hepatology (Baltimore, Md.)|November 30, 2006
Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?Fabien Zoulim
Pageof 50

Showing results (21-30 of 499) with videos related to

Sort By:
Pageof 50
Journal of Hepatology|May 24, 2003
Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?Fabien Zoulim
Antiviral Research|September 25, 2012
Are novel combination therapies needed for chronic hepatitis B?Fabien Zoulim
Gastroenterologie Clinique Et Biologique|April 9, 2002
[Toward the expected development of therapeutic combinations in hepatitis B?]Fabien Zoulim
Expert Opinion on Emerging Drugs|July 3, 2007
Emerging drugs for hepatitis BFabien Zoulim
Journal of Hepatology|February 16, 2005
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNAFabien Zoulim
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Hepatitis B virus resistance to antiviral drugs: where are we going?Fabien Zoulim
Presse Medicale (Paris, France : 1983)|November 29, 2007
[Current data on the treatment of chronic hepatitis B]Fabien Zoulim
Journal of Hepatology|December 9, 2017
Inhibition of hepatitis B virus gene expression: A step towards functional cureFabien Zoulim
Seminars in Liver Disease|May 5, 2006
In vitro models for studying hepatitis B virus drug resistanceFabien Zoulim
Hepatology (Baltimore, Md.)|November 30, 2006
Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?Fabien Zoulim
Pageof 50